If you are exploring IVF in Thailand and have a known genetic condition or a chromosomal rearrangement, you may come across two specific types of preimplantation genetic testing: PGT-M and PGT-SR. Both are performed on embryos created through IVF, but they screen for different types of genetic issues. Understanding the difference can help you have more informed conversations with your fertility team.
At a Glance: PGT-M vs. PGT-SR
- PGT-M screens for specific single gene disorders, such as cystic fibrosis, sickle cell anemia, or Huntington’s disease.
- PGT-SR screens for chromosomal structural rearrangements, such as translocations or inversions, which can affect embryo development.
- Both tests require IVF and embryo biopsy, and they are performed before embryo transfer.
- Availability and specific protocols may vary between clinics in Thailand, so it’s important to ask about their laboratory capabilities.
What Is PGT-M?
PGT-M stands for preimplantation genetic testing for monogenic (single gene) disorders. It is used when one or both partners carry a known mutation for a specific genetic condition. The test looks for the presence or absence of that particular mutation in embryos created through IVF.
PGT-M is typically considered by couples who:
- Have a family history of a single gene disorder.
- Are known carriers of an autosomal recessive or autosomal dominant condition.
- Have a sex-linked disorder that they wish to avoid passing on.
The goal is to identify embryos that do not carry the specific mutation, so that only those embryos are considered for transfer. However, PGT-M does not screen for all genetic conditions or chromosomal abnormalities—it is targeted to the specific mutation being tested.
What Is PGT-SR?
PGT-SR stands for preimplantation genetic testing for chromosomal structural rearrangements. This test is used when one or both partners have a chromosomal rearrangement, such as a balanced translocation or an inversion. These rearrangements may not cause health problems in the carrier, but they can lead to embryos with unbalanced chromosomal material, which may result in miscarriage or developmental issues.
PGT-SR is typically considered by couples who:
- Have a known balanced translocation or inversion.
- Have experienced recurrent pregnancy loss or infertility that may be linked to chromosomal rearrangements.
The test identifies embryos with a normal or balanced chromosomal arrangement, which are more likely to lead to a successful pregnancy.
Key Differences Between PGT-M and PGT-SR
| Aspect | PGT-M | PGT-SR |
|---|---|---|
| What it screens for | Specific single gene mutations | Chromosomal structural rearrangements |
| Typical candidates | Carriers of known genetic disorders | Carriers of balanced translocations or inversions |
| Method | Targeted analysis for a specific mutation | Analysis of chromosomal structure |
| Outcome | Identifies embryos without the specific mutation | Identifies embryos with normal or balanced chromosomes |
How Are PGT-M and PGT-SR Performed?
Both PGT-M and PGT-SR require IVF to create embryos. After fertilization, a small number of cells are removed from each embryo (a process called biopsy) and sent to a genetics laboratory for analysis. The testing process typically takes several days, after which the results are used to select embryos for transfer.
In Thailand, the availability of PGT-M and PGT-SR may depend on the clinic’s laboratory capabilities and partnerships with genetics labs. Some clinics may offer both tests, while others may refer embryos to an external laboratory. It’s important to ask about the specific testing platform and turnaround time.
Questions to Ask Your Clinic in Thailand
When considering PGT-M or PGT-SR in Thailand, it’s helpful to ask your clinic specific questions to understand your options:
- Do you offer PGT-M and PGT-SR on-site, or do you work with an external genetics laboratory?
- What is the experience of your laboratory with these specific tests?
- How long does the testing process take, and how does that affect the IVF timeline?
- What are the costs associated with PGT-M or PGT-SR, and are they included in any IVF packages?
- What are the limitations of the testing, and what results are possible (e.g., inconclusive, no result)?
- How are embryos with abnormal results handled, and what are the options for disposal, donation, or further testing?
Limitations and Considerations
It’s important to understand that PGT-M and PGT-SR are not guarantees of a successful pregnancy or a healthy child. They are screening tools that can reduce the risk of transferring an embryo with a specific genetic issue, but they do not eliminate all risks. For example:
- PGT-M only tests for the specific mutation requested; it does not screen for other genetic or chromosomal conditions.
- PGT-SR may not detect all types of chromosomal rearrangements, and some embryos may have mosaicism (a mix of normal and abnormal cells).
- Embryo biopsy carries a small risk of damage to the embryo, though this is rare.
- Not all embryos may be suitable for testing, and some may not survive the biopsy process.
Additionally, the accuracy of PGT depends on the laboratory’s techniques and the quality of the embryo biopsy. It’s essential to discuss the limitations with your fertility specialist and genetic counselor.
Next Steps
If you are considering PGT-M or PGT-SR in Thailand, here are some steps to help you move forward:
- Consult with a fertility specialist to review your medical history and determine if PGT is appropriate.
- Meet with a genetic counselor to understand the specific condition or rearrangement and the implications for your family.
- Ask your clinic about their experience with PGT-M and PGT-SR, including success rates and laboratory protocols.
- Clarify the costs, timeline, and any additional procedures required.
- Consider the emotional and ethical aspects of embryo testing and discuss them with your partner and support network.
For more general information about PGT in Thailand, you can visit our PGT in Thailand page. You may also find our guides and FAQ sections helpful as you research your options.
Frequently asked questions
Can PGT-M and PGT-SR be done at the same time?
Yes, it is possible to perform PGT-M and PGT-SR simultaneously on the same embryo biopsy, if both are indicated. This would require a laboratory that can analyze both the specific gene mutation and the chromosomal structure. However, not all clinics may offer combined testing, so it's important to ask about their capabilities.
What is the difference between PGT-A, PGT-M, and PGT-SR?
PGT-A (preimplantation genetic testing for aneuploidy) screens embryos for the correct number of chromosomes, which can help identify embryos with a higher chance of implantation. PGT-M screens for specific single gene disorders, and PGT-SR screens for chromosomal structural rearrangements. They are used for different purposes and may be used alone or in combination.
Are PGT-M and PGT-SR available in all IVF clinics in Thailand?
Availability may vary. Some clinics in Thailand have on-site genetics laboratories, while others may partner with external labs. It's best to ask your clinic directly about their PGT-M and PGT-SR services, including the specific testing platforms they use.
How long does PGT-M or PGT-SR testing take?
The testing process typically takes several days to a few weeks, depending on the laboratory and the complexity of the test. Your clinic can provide a more specific timeline based on their protocols.
What are the risks of PGT-M and PGT-SR?
The main risks are related to the IVF process and embryo biopsy. There is a small risk of embryo damage during biopsy, and the testing itself may have limitations, such as inconclusive results. It's important to discuss these risks with your fertility team.
Continue your research
Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.